34486218|t|Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.
34486218|a|Multiple system atrophy (MSA) is a fatal neurodegenerative disease where the histopathological hallmark is glial cytoplasmic inclusions in oligodendrocytes, rich of aggregated alpha-synuclein (aSyn). Therefore, therapies targeting aSyn aggregation and toxicity have been studied as a possible disease-modifying therapy for MSA. Our earlier studies show that inhibition of prolyl oligopeptidase (PREP) with KYP-2047 reduces aSyn aggregates in several models. Here, we tested the effects of KYP-2047 on a MSA cellular models, using rat OLN-AS7 and human MO3.13 oligodendrocyte cells. As translocation of p25alpha to cell cytosol has been identified as an inducer of aSyn aggregation in MSA models, the cells were transiently transfected with p25alpha. Similar to earlier studies, p25alpha increased aSyn phosphorylation and aggregation, and caused tubulin retraction and impaired autophagy in OLN-AS7 cells. In both cellular models, p25alpha transfection increased significantly aSyn mRNA levels and also increased the levels of inactive protein phosphatase 2A (PP2A). However, aSyn or p25alpha did not cause any cellular death in MO3.13 cells, questioning their use as a MSA model. Simultaneous administration of 10 microM KYP-2047 improved cell viability, decreased insoluble phosphorylated aSyn and normalized autophagy in OLN-AS7 cells but similar impact was not seen in MO3.13 cells.
34486218	0	21	Prolyl oligopeptidase	Gene	83471
34486218	41	56	alpha-synuclein	Gene	6622
34486218	92	115	multiple system atrophy	Disease	MESH:D019578
34486218	117	140	Multiple system atrophy	Disease	MESH:D019578
34486218	142	145	MSA	Disease	MESH:D019578
34486218	158	183	neurodegenerative disease	Disease	MESH:D019636
34486218	293	308	alpha-synuclein	Gene	6622
34486218	369	377	toxicity	Disease	MESH:D064420
34486218	440	443	MSA	Disease	MESH:D019578
34486218	489	510	prolyl oligopeptidase	Gene	83471
34486218	512	516	PREP	Gene	83471
34486218	523	531	KYP-2047	Chemical	MESH:C551540
34486218	606	614	KYP-2047	Chemical	MESH:C551540
34486218	620	623	MSA	Disease	MESH:D019578
34486218	647	650	rat	Species	10116
34486218	651	658	OLN-AS7	CellLine	CVCL:5850
34486218	663	668	human	Species	9606
34486218	669	675	MO3.13	CellLine	CVCL:D357
34486218	719	727	p25alpha	Gene	11076
34486218	801	804	MSA	Disease	MESH:D019578
34486218	857	865	p25alpha	Gene	11076
34486218	895	903	p25alpha	Gene	11076
34486218	1008	1015	OLN-AS7	CellLine	CVCL:5850
34486218	1048	1056	p25alpha	Gene	11076
34486218	1177	1181	PP2A	Gene	5524
34486218	1201	1209	p25alpha	Gene	11076
34486218	1246	1252	MO3.13	CellLine	CVCL:D357
34486218	1287	1290	MSA	Disease	MESH:D019578
34486218	1339	1347	KYP-2047	Chemical	MESH:C551540
34486218	1441	1448	OLN-AS7	CellLine	CVCL:5850
34486218	1490	1496	MO3.13	CellLine	CVCL:D357
34486218	Association	MESH:D019578	6622
34486218	Positive_Correlation	11076	5524
34486218	Negative_Correlation	MESH:C551540	83471
34486218	Association	6622	83471

